Swish and spit of an oral rinse is much easier on the

New Post Public Reply Private Reply Replies (1) Message Board
Drano bandg #40050
428
Swish and spit of an oral rinse is much easier on the patient that dissolving any lozenge, whether it's intended to be an oral lozenge or a suppository for some other body part. Anyone who has ever experienced both methods will tell you that a rinse is much easier than trying to dissolve a lozenge in your mouth -- especially if one is dehydrated and struggling to produce saliva -- and also, when you are trying to dissolve a lozenge, the natural impulse is to try to suck on it, which draws the cheeks inward and would be extraordinarily painful for someone with OM. And, a lozenge delivery guarantees that much of the drug will be swallowed -- a huge disadvantage, along with the disadvantage of not achieving the kind of coverage achieved with a rinse. Swish and spit is by far the easiest and least painful method of delivery for an OM patient. It's a quicker process which is a huge plus for a desperately ill patient. Additionally, it will result in less ingestion of Brilacidin, which is important in avoiding systemic exposure.

Please note that I pointed out specifically for the sake of readers who might have skimmed your post, that you were not suggesting Fluconazole for OM. I am not the one who needs to read posts more carefully.

As far as your snark about my several flu vaccine posts, I repeat that the renowned biologist who had the experience of getting flu immediately after the shot discovered that others likewise had gotten ill immediately after the shot, and the conclusion by the clinic and the scientist was that the supposedly "attenuated" virus was in fact a live virus in a vaccine that had not been manufactured properly. Had you spent even more time than you did searching my posts so that you could come up with one from several weeks ago, you would be aware of that.

Posts from people claiming to be medical professionals are often regarded with more deference than those from non-medical posters. It took me all of two minutes to determine that there was no such thing as a Fluconazole vaginal suppository, but that there was a highly effective oral rinse. And I, a non-physician, knew the correct name of the drug. As Spiderman's uncle says, "With great power comes great responsibility."



Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading